Discover how a multidisciplinary panel of thyroid endocrinologists, surgeons, and pathologists are transforming thyroid nodule and cancer care through the integration of molecular markers. In this webinar, experts share real-world cases and insights on using molecular diagnostics and prognostics to guide clinical and surgical decisions, emphasizing the value of personalized patient care.
Gain a deeper understanding of the evolution of molecular medicine in thyroid care, from improving diagnostic precision to identifying therapeutic targets and enhancing prognostic tools to advance treatment strategies and patient outcomes.
- Moderator: Erik Alexander, M.D., Chief of Thyroid Section, Brigham and Women’s Hospital & Professor of Medicine & Associate Dean of Medical Education, Harvard Medical School
- Trevor Angel, M.D., Assistant Professor of Clinical Medicine and Associate Director of the Thyroid Center in the Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California
- Nancy Cho, M.D., Assistant Professor of Surgery, Harvard Medical School; Co-Director of Endocrine Surgery, Brigham & Women’s Hospital
- Peter Sadow, M.D., PhD, Associate Professor of Pathology, Harvard Medical School & Director of Head & Neck Pathology, Massachusetts General Hospital
Watch today and let’s continue to collectively improve thyroid cancer care.
Working together with the cancer research community, our mission is to advance thyroid cancer care with exceptional genomic testing for personalized treatment planning.
Key topics
- 0:00 – Application of Molecular Knowledge
- 9:30 – Real-world Cases
- 18:00 – Cancer Risk Refinement
- 24:00 – From Mutations to Prognostic Classes
- 32:00 – Molecular Data & Operative Approach
- 34:00 – Somatic Vs. Germ-line Mutations
- 43:00 – Unique Molecular Findings
Speakers
Erik Alexander, M.D.
Brigham and Women’s Hospital
Trevor Angell, M.D.
Keck Medical Center, USC
Nancy L. Cho, M.D.
Peter Sadow, M.D.
Tags
On Demand
Afirma Thyroid